Treatment for deadly yeast disease reduced to three days

April 24, 2014
Treatment for deadly yeast disease reduced to three days
The team found the treatment for the deadly brain infection had the same effect after three days, as after the recommended two weeks

(Medical Xpress)—Initial treatment for a brain infection caused by fungus could now be treated in three days, rather than two weeks, due to study by University of Liverpool scientists.

Cryptococcus – a form of yeast – infections are often fatal but are relatively neglected in . They are found in many parts of the world, including Africa, Australasia and South East Asia and mainly affect people with . This infection kills up to 700,000 people a year.

Cryptococcus

The University research team tested the effects of the most commonly used drug on Cryptococcus infections of the brain and discovered that although the recommendation for is currently two weeks, the drug has been shown by the new studies to be effective at clearing the fungus within three days.

Professor of Therapeutics and Infectious Diseases, William Hope said: "This infection kills up to 700,000 people a year and is mainly fatal in areas with poor resources. In many parts of the world it is simply unfeasible to administer for two weeks."

The scientists in the Institute of Translational Medicine examined the effects of amphotericin B deoxycholate (dAmB) over both three and 14 day treatments and found that the effect was the same after three days as it was after two weeks.

The results in animal trials was compared with humans using a range of mathematical modelling techniques, to produce findings which suggest that the three day regime will be equally as effective in people.

The researchers believe that this opens up significant possibilities for treatment in areas where there is a scarcity of medically trained staff, who often have to ration the drugs they administer to patients.

The infection often takes hold in people with AIDS as a result of their immune systems being compromised, and areas with high rates of AIDS are also usually those without resources.

Accelerate changes

Professor Hope added: "A lot of the treatment administered with a variety of drugs is assumed and generalised. This is one example of how experimental medicine can help accelerate changes to improve outcomes for patients."

The next stage of the research will be to test it in clinical trials in humans. The findings were published in the journal mBio.

Explore further: Breast cancer drug fights fungal disease

Related Stories

Breast cancer drug fights fungal disease

February 11, 2014
Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more ...

Scientists discover how a killer fungus attacks HIV patients

April 23, 2014
Researchers have discovered that a type of white blood cell carries a deadly fungus into the brains of HIV positive patients, causing meningitis which kills more than 600,000 people a year.

Combo therapy helps knock out fungal meningitis

April 3, 2013
(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B ...

Breakthrough treatment for hepatitis C

April 15, 2014
(Medical Xpress)—A breakthrough treatment for hepatitis C that halves treatment time has been developed in an international clinical trial that included The University of Queensland.

New investigational drug holds promise for combatting deadly mucormycosis infections

February 6, 2014
With very few treatment options available to fight deadly mucormycosis infections, a new Los Angeles Biomedical Research Institute (LA BioMed) study holds hope for adding to the arsenal of therapies physicians have to combat ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.